![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Bioindustria L.i.m. S.p.a. Novi Ligure It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Production of small & large volume I.V. Solutions// Generic Drug Products// APIs// GMP certified.
One of their significant offerings is Hyaluronidase, supported by a 'Suspended by EDQM GMP non-compliance' Certificate of Suitability (CEP) with the number R1-CEP 2001-068 - Rev 00
This TSE Type CEP, issued on April 04, 2007, remains in force until March 30, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 912 associated with this CEP further emphasizes